American International Group, Inc. Allogene Therapeutics, Inc. Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$2.92 - $5.63 $1,168 - $2,252	-400 Reduced 0.85%	46,567 $208,000
Q4 2023 Feb 13, 2024	BUY	$2.28 - $3.5 $13,577 - $20,842	5,955 Added 14.52%	46,967 $150,000
Q3 2023 Nov 13, 2023	BUY	$3.17 - $5.96 $4,625 - $8,695	1,459 Added 3.69%	41,012 $130,000
Q2 2023 Aug 04, 2023	BUY	$4.53 - $6.74 $4,937 - $7,346	1,090 Added 2.83%	39,553 $196,000
Q1 2023 May 12, 2023	BUY	$4.92 - $8.21 $3,763 - $6,280	765 Added 2.03%	38,463 $190,000
Q4 2022 Feb 10, 2023	SELL	$5.62 - $11.11 $769 - $1,522	-137 Reduced 0.36%	37,698 $237,000
Q3 2022 Nov 14, 2022	BUY	$10.32 - $17.28 $5,510 - $9,227	534 Added 1.43%	37,835 $409,000
Q2 2022 Aug 12, 2022	BUY	$6.78 - $12.28 $24,001 - $43,471	3,540 Added 10.49%	37,301 $425,000
Q1 2022 May 13, 2022	SELL	$7.65 - $15.29 $18,176 - $36,329	-2,376 Reduced 6.57%	33,761 $308,000
Q4 2021 Feb 11, 2022	SELL	$13.13 - $24.52 $14,193 - $26,506	-1,081 Reduced 2.9%	36,137 $539,000
Q3 2021 Nov 12, 2021	SELL	$21.01 - $27.64 $18,593 - $24,461	-885 Reduced 2.32%	37,218 $957,000
Q2 2021 Aug 13, 2021	BUY	$23.49 - $35.8 $156,913 - $239,143	6,680 Added 21.26%	38,103 $994,000
Q1 2021 May 07, 2021	BUY	$25.79 - $39.02 $2,140 - $3,238	83 Added 0.26%	31,423 $1.11 Million
Q4 2020 Feb 12, 2021	SELL	$25.24 - $43.45 $22,716 - $39,105	-900 Reduced 2.79%	31,340 $791,000
Q3 2020 Nov 04, 2020	BUY	$32.38 - $44.96 $83,281 - $115,637	2,572 Added 8.67%	32,240 $1.22 Million
Q2 2020 Aug 12, 2020	BUY	$18.39 - $54.04 $123,323 - $362,392	6,706 Added 29.2%	29,668 $1.27 Million
Q1 2020 May 04, 2020	SELL	$18.22 - $28.25 $24,159 - $37,459	-1,326 Reduced 5.46%	22,962 $446,000
Q4 2019 Feb 05, 2020	SELL	$24.82 - $31.4 $5,088 - $6,437	-205 Reduced 0.84%	24,288 $631,000
Q3 2019 Nov 08, 2019	SELL	$26.11 - $32.99 $4,464 - $5,641	-171 Reduced 0.69%	24,493 $668,000
Q2 2019 Aug 13, 2019	BUY	$25.56 - $31.09 $271,370 - $330,082	10,617 Added 75.58%	24,664 $662,000
Q1 2019 May 06, 2019	SELL	$24.82 - $32.54 $769 - $1,008	-31 Reduced 0.22%	14,047 $406,000
Q4 2018 Feb 13, 2019	BUY	$22.5 - $33.3 $316,755 - $468,797	14,078 New	14,078 $379,000

Others Institutions Holding ALLO

# of Institutions

162

Shares Held

134M

Call Options Held

59.4K

Put Options Held

113K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $326M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account